Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 4454 entries
Sorted by: Best Match Show Resources per page
Current approaches and advance in mantle cell lymphoma treatment.

Stem cell investigation

Liu Y, Zhang X, Zhong JF.
PMID: 27358886
Stem Cell Investig. 2015 Sep 29;2:18. doi: 10.3978/j.issn.2306-9759.2015.09.02. eCollection 2015.

Mantle cell lymphoma (MCL) is a set of heterogeneous non-Hodgkin lymphoma characterized by involvement of lymph nodes, spleen, bone marrow and blood. Under conventional treatment, survival time is 4 to 5 years with short remission period and there is...

Cite
Liu Y, Zhang X, Zhong JF. Current approaches and advance in mantle cell lymphoma treatment. Stem Cell Investig. 2015;2:18doi: 10.3978/j.issn.2306-9759.2015.09.02.
Liu, Y., Zhang, X., & Zhong, J. F. (2015). Current approaches and advance in mantle cell lymphoma treatment. Stem cell investigation, 218. https://doi.org/10.3978/j.issn.2306-9759.2015.09.02
Liu, Yao, et al. "Current approaches and advance in mantle cell lymphoma treatment." Stem cell investigation vol. 2 (2015): 18. doi: https://doi.org/10.3978/j.issn.2306-9759.2015.09.02
Liu Y, Zhang X, Zhong JF. Current approaches and advance in mantle cell lymphoma treatment. Stem Cell Investig. 2015 Sep 29;2:18. doi: 10.3978/j.issn.2306-9759.2015.09.02. eCollection 2015. PMID: 27358886; PMCID: PMC4923656.
Copy Download .nbib Format: NLM
Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia.

OncoTargets and therapy

Huber H, Edenhofer S, Estenfelder S, Stilgenbauer S.
PMID: 28223822
Onco Targets Ther. 2017 Feb 07;10:645-656. doi: 10.2147/OTT.S102646. eCollection 2017.

Over the last few years, dramatic changes have occurred in the treatment of chronic lymphocytic leukemia (CLL). The current standard for young and fit patients with CLL remains chemoimmunotherapy, namely the fludarabine, cyclophosphamide, and rituximab (FCR) regimen. However, novel...

Cite
Huber H, Edenhofer S, Estenfelder S, et al. Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia. Onco Targets Ther. 2017;10:645-656doi: 10.2147/OTT.S102646.
Huber, H., Edenhofer, S., Estenfelder, S., & Stilgenbauer, S. (2017). Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia. OncoTargets and therapy, 10645-656. https://doi.org/10.2147/OTT.S102646
Huber, Henriette, et al. "Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia." OncoTargets and therapy vol. 10 (2017): 645-656. doi: https://doi.org/10.2147/OTT.S102646
Huber H, Edenhofer S, Estenfelder S, Stilgenbauer S. Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia. Onco Targets Ther. 2017 Feb 07;10:645-656. doi: 10.2147/OTT.S102646. eCollection 2017. PMID: 28223822; PMCID: PMC5308588.
Copy Download .nbib Format: NLM
Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia.

Experimental hematology & oncology

Garrote H, de la Fuente A, Oña R, Rodríguez I, Echevarría JE, Sepúlveda JM, García JF.
PMID: 25767742
Exp Hematol Oncol. 2015 Mar 01;4:8. doi: 10.1186/s40164-015-0003-4. eCollection 2015.

A 50-year-old male with chronic lymphocytic leukemia (CLL) was treated with fludarabine, cyclophosphamide and rituximab, which produced a complete remission. Eight months after the last dose of rituximab he had visual disturbance, diminished muscular strength in the right arm...

Cite
Garrote H, de la Fuente A, Oña R, et al. Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia. Exp Hematol Oncol. 2015;4:8doi: 10.1186/s40164-015-0003-4.
Garrote, H., de la Fuente, A., Oña, R., Rodríguez, I., Echevarría, J. E., Sepúlveda, J. M., & García, J. F. (2015). Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia. Experimental hematology & oncology, 48. https://doi.org/10.1186/s40164-015-0003-4
Garrote, Heidys, et al. "Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia." Experimental hematology & oncology vol. 4 (2015): 8. doi: https://doi.org/10.1186/s40164-015-0003-4
Garrote H, de la Fuente A, Oña R, Rodríguez I, Echevarría JE, Sepúlveda JM, García JF. Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia. Exp Hematol Oncol. 2015 Mar 01;4:8. doi: 10.1186/s40164-015-0003-4. eCollection 2015. PMID: 25767742; PMCID: PMC4357158.
Copy Download .nbib Format: NLM
Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature.

Journal of clinical medicine research

Li X, Wang Y.
PMID: 27298667
J Clin Med Res. 2016 Jul;8(7):555-9. doi: 10.14740/jocmr2550w. Epub 2016 May 29.

We recently encountered a patient with acute inflammatory demyelinating polyneuropathy (AIDP) that was associated with systemic lupus erythematosus (SLE). A 34-year-old Chinese female with a 3-year history of SLE presented with acute bilateral leg weakness and paraparesis, and lost...

Cite
Li X, Wang Y. Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature. J Clin Med Res. 2016;8(7):555-9doi: 10.14740/jocmr2550w.
Li, X., & Wang, Y. (2016). Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature. Journal of clinical medicine research, 8(7), 555-9. https://doi.org/10.14740/jocmr2550w
Li, Xiangling, and Wang, Yanqiang. "Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature." Journal of clinical medicine research vol. 8,7 (2016): 555-9. doi: https://doi.org/10.14740/jocmr2550w
Li X, Wang Y. Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature. J Clin Med Res. 2016 Jul;8(7):555-9. doi: 10.14740/jocmr2550w. Epub 2016 May 29. PMID: 27298667; PMCID: PMC4894028.
Copy Download .nbib Format: NLM
Alveolar rhabdomyosarcoma with massive disseminated intravascular coagulopathy treated with systemic chemotherapy.

Korean journal of pediatrics

Yoon BG, Baek HJ, Oh BS, Han DK, Choi YD, Kook H.
PMID: 26770227
Korean J Pediatr. 2015 Dec;58(12):505-8. doi: 10.3345/kjp.2015.58.12.505. Epub 2015 Dec 22.

It is uncommon for pediatric patients with rhabdomyosarcoma to present with clinical and/or laboratory features of disseminated intravascular coagulation (DIC). We report a case of metastatic alveolar rhabdomyosarcoma with severe bleeding because of DIC in a 13-year-old boy. He...

Cite
Yoon BG, Baek HJ, Oh BS, et al. Alveolar rhabdomyosarcoma with massive disseminated intravascular coagulopathy treated with systemic chemotherapy. Korean J Pediatr. 2015;58(12):505-8doi: 10.3345/kjp.2015.58.12.505.
Yoon, B. G., Baek, H. J., Oh, B. S., Han, D. K., Choi, Y. D., & Kook, H. (2015). Alveolar rhabdomyosarcoma with massive disseminated intravascular coagulopathy treated with systemic chemotherapy. Korean journal of pediatrics, 58(12), 505-8. https://doi.org/10.3345/kjp.2015.58.12.505
Yoon, Byung Gyu, et al. "Alveolar rhabdomyosarcoma with massive disseminated intravascular coagulopathy treated with systemic chemotherapy." Korean journal of pediatrics vol. 58,12 (2015): 505-8. doi: https://doi.org/10.3345/kjp.2015.58.12.505
Yoon BG, Baek HJ, Oh BS, Han DK, Choi YD, Kook H. Alveolar rhabdomyosarcoma with massive disseminated intravascular coagulopathy treated with systemic chemotherapy. Korean J Pediatr. 2015 Dec;58(12):505-8. doi: 10.3345/kjp.2015.58.12.505. Epub 2015 Dec 22. PMID: 26770227; PMCID: PMC4705332.
Copy Download .nbib Format: NLM
Treatment associated Mantle Cell Lymphoma with Cyclophosphamide therapy for Granulomatosis with Polyangiitis.

Respirology case reports

Sheehy R, Tran K.
PMID: 25802740
Respirol Case Rep. 2015 Mar;3(1):6-8. doi: 10.1002/rcr2.87. Epub 2014 Dec 04.

We present a case of a 68-year-old woman who developed mantle cell lymphoma in the setting of long-term cyclophosphamide therapy and relapsing granulomatosis with polyangiitis (Wegener's granulomatosis, GPA). Adverse outcomes associated with cyclophosphamide therapy are well documented; however, the...

Cite
Sheehy R, Tran K. Treatment associated Mantle Cell Lymphoma with Cyclophosphamide therapy for Granulomatosis with Polyangiitis. Respirol Case Rep. 2014;3(1):6-8doi: 10.1002/rcr2.87.
Sheehy, R., & Tran, K. (2015). Treatment associated Mantle Cell Lymphoma with Cyclophosphamide therapy for Granulomatosis with Polyangiitis. Respirology case reports, 3(1), 6-8. https://doi.org/10.1002/rcr2.87
Sheehy, Robert, and Tran, Khoa. "Treatment associated Mantle Cell Lymphoma with Cyclophosphamide therapy for Granulomatosis with Polyangiitis." Respirology case reports vol. 3,1 (2015): 6-8. doi: https://doi.org/10.1002/rcr2.87
Sheehy R, Tran K. Treatment associated Mantle Cell Lymphoma with Cyclophosphamide therapy for Granulomatosis with Polyangiitis. Respirol Case Rep. 2015 Mar;3(1):6-8. doi: 10.1002/rcr2.87. Epub 2014 Dec 04. PMID: 25802740; PMCID: PMC4364788.
Copy Download .nbib Format: NLM
Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag.

Case reports in hematology

Anwer F, Yun S, Nair A, Ahmad Y, Krishnadashan R, Deeg HJ.
PMID: 26180646
Case Rep Hematol. 2015;2015:583451. doi: 10.1155/2015/583451. Epub 2015 Jun 09.

Severe refractory ITP is clinically challenging and a variety of single or combination chemotherapies have been tried with limited outcome. We report a case of ITP that was unresponsive to multiple agents including high-dose steroid, IVIG, Rho(D) immune globulin,...

Cite
Anwer F, Yun S, Nair A, et al. Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag. Case Rep Hematol. 2015;2015:583451doi: 10.1155/2015/583451.
Anwer, F., Yun, S., Nair, A., Ahmad, Y., Krishnadashan, R., & Deeg, H. J. (2015). Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag. Case reports in hematology, 2015583451. https://doi.org/10.1155/2015/583451
Anwer, Faiz, et al. "Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag." Case reports in hematology vol. 2015 (2015): 583451. doi: https://doi.org/10.1155/2015/583451
Anwer F, Yun S, Nair A, Ahmad Y, Krishnadashan R, Deeg HJ. Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag. Case Rep Hematol. 2015;2015:583451. doi: 10.1155/2015/583451. Epub 2015 Jun 09. PMID: 26180646; PMCID: PMC4477130.
Copy Download .nbib Format: NLM
Successful induction of granulomatosis with polyangiitis with tacrolimus.

Indian journal of nephrology

Ramachandran R, Tiwana S, Prabhakar D, Gowda K, Nada R, Kumar V, Rathi M, Kohli HS, Jha V, Gupta KL, Sakhuja V.
PMID: 25684872
Indian J Nephrol. 2015 Jan-Feb;25(1):46-9. doi: 10.4103/0971-4065.136885.

We report a 50-year-old female who presented with inflammatory arthritis, upper respiratory tract symptoms, and microscopic hematuria with nephrotic range proteinuria. Antineutrophil cytoplasmic antibodies (ANCA) were detectable and kidney biopsy showed pauci-immune focal necrotizing crescentic glomerulonephritis. She was treated...

Cite
Ramachandran R, Tiwana S, Prabhakar D, et al. Successful induction of granulomatosis with polyangiitis with tacrolimus. Indian J Nephrol. 2015;25(1):46-9doi: 10.4103/0971-4065.136885.
Ramachandran, R., Tiwana, S., Prabhakar, D., Gowda, K., Nada, R., Kumar, V., Rathi, M., Kohli, H. S., Jha, V., Gupta, K. L., & Sakhuja, V. (2015). Successful induction of granulomatosis with polyangiitis with tacrolimus. Indian journal of nephrology, 25(1), 46-9. https://doi.org/10.4103/0971-4065.136885
Ramachandran, R, et al. "Successful induction of granulomatosis with polyangiitis with tacrolimus." Indian journal of nephrology vol. 25,1 (2015): 46-9. doi: https://doi.org/10.4103/0971-4065.136885
Ramachandran R, Tiwana S, Prabhakar D, Gowda K, Nada R, Kumar V, Rathi M, Kohli HS, Jha V, Gupta KL, Sakhuja V. Successful induction of granulomatosis with polyangiitis with tacrolimus. Indian J Nephrol. 2015 Jan-Feb;25(1):46-9. doi: 10.4103/0971-4065.136885. PMID: 25684872; PMCID: PMC4323912.
Copy Download .nbib Format: NLM
Refractory optic perineuritis due to granulomatosis with polyangiitis successfully treated with methotrexate and mycophenolate mofetil combination therapy.

European journal of rheumatology

Kimura Y, Asako K, Kikuchi H, Kono H.
PMID: 28293459
Eur J Rheumatol. 2017 Mar;4(1):70-72. doi: 10.5152/eurjrheum.2016.028. Epub 2017 Mar 01.

Optic perineuritis is an uncommon inflammatory disorder of the optic sheath that causes visual loss or eye pain. There are few case reports of optic perineuritis associated with granulomatosis with polyangiitis. Herein we report the case of a 37-year-old...

Cite
Kimura Y, Asako K, Kikuchi H, et al. Refractory optic perineuritis due to granulomatosis with polyangiitis successfully treated with methotrexate and mycophenolate mofetil combination therapy. Eur J Rheumatol. 2017;4(1):70-72doi: 10.5152/eurjrheum.2016.028.
Kimura, Y., Asako, K., Kikuchi, H., & Kono, H. (2017). Refractory optic perineuritis due to granulomatosis with polyangiitis successfully treated with methotrexate and mycophenolate mofetil combination therapy. European journal of rheumatology, 4(1), 70-72. https://doi.org/10.5152/eurjrheum.2016.028
Kimura, Yoshitaka, et al. "Refractory optic perineuritis due to granulomatosis with polyangiitis successfully treated with methotrexate and mycophenolate mofetil combination therapy." European journal of rheumatology vol. 4,1 (2017): 70-72. doi: https://doi.org/10.5152/eurjrheum.2016.028
Kimura Y, Asako K, Kikuchi H, Kono H. Refractory optic perineuritis due to granulomatosis with polyangiitis successfully treated with methotrexate and mycophenolate mofetil combination therapy. Eur J Rheumatol. 2017 Mar;4(1):70-72. doi: 10.5152/eurjrheum.2016.028. Epub 2017 Mar 01. PMID: 28293459; PMCID: PMC5335893.
Copy Download .nbib Format: NLM
Anti-glomerular basement membrane disease: Case series from a tertiary center in North India.

Indian journal of nephrology

Prabhakar D, Rathi M, Nada R, Minz RW, Kumar V, Kohli HS, Jha V, Gupta KL.
PMID: 28356661
Indian J Nephrol. 2017 Mar-Apr;27(2):108-112. doi: 10.4103/0971-4065.171227.

Anti-glomerular basement (anti-GBM) disease is an uncommon disorder with a bimodal age of presentation. Patients presenting with dialysis-dependent renal failure have poor renal outcomes. There is limited data regarding the clinical presentation and outcomes of anti-GBM disease from India....

Cite
Prabhakar D, Rathi M, Nada R, et al. Anti-glomerular basement membrane disease: Case series from a tertiary center in North India. Indian J Nephrol. 2017;27(2):108-112doi: 10.4103/0971-4065.171227.
Prabhakar, D., Rathi, M., Nada, R., Minz, R. W., Kumar, V., Kohli, H. S., Jha, V., & Gupta, K. L. (2017). Anti-glomerular basement membrane disease: Case series from a tertiary center in North India. Indian journal of nephrology, 27(2), 108-112. https://doi.org/10.4103/0971-4065.171227
Prabhakar, D, et al. "Anti-glomerular basement membrane disease: Case series from a tertiary center in North India." Indian journal of nephrology vol. 27,2 (2017): 108-112. doi: https://doi.org/10.4103/0971-4065.171227
Prabhakar D, Rathi M, Nada R, Minz RW, Kumar V, Kohli HS, Jha V, Gupta KL. Anti-glomerular basement membrane disease: Case series from a tertiary center in North India. Indian J Nephrol. 2017 Mar-Apr;27(2):108-112. doi: 10.4103/0971-4065.171227. PMID: 28356661; PMCID: PMC5358149.
Copy Download .nbib Format: NLM
Arteriovenous Fistula Embolization in Suspected Parauterine Choriocarcinoma.

Case reports in obstetrics and gynecology

Alturkistani H, Almarzooqi MK, Oliva V, Gilbert P.
PMID: 27403360
Case Rep Obstet Gynecol. 2016;2016:6353471. doi: 10.1155/2016/6353471. Epub 2016 Jun 14.

This is a case of choriocarcinoma that did not regress after chemotherapy treatment. A 30-year-old female patient (gravida 2, para 2), presented to our ER with stroke and persistent mild pelvic pain 2 months after a Caesarean section. Computed...

Cite
Alturkistani H, Almarzooqi MK, Oliva V, et al. Arteriovenous Fistula Embolization in Suspected Parauterine Choriocarcinoma. Case Rep Obstet Gynecol. 2016;2016:6353471doi: 10.1155/2016/6353471.
Alturkistani, H., Almarzooqi, M. K., Oliva, V., & Gilbert, P. (2016). Arteriovenous Fistula Embolization in Suspected Parauterine Choriocarcinoma. Case reports in obstetrics and gynecology, 20166353471. https://doi.org/10.1155/2016/6353471
Alturkistani, Husain, et al. "Arteriovenous Fistula Embolization in Suspected Parauterine Choriocarcinoma." Case reports in obstetrics and gynecology vol. 2016 (2016): 6353471. doi: https://doi.org/10.1155/2016/6353471
Alturkistani H, Almarzooqi MK, Oliva V, Gilbert P. Arteriovenous Fistula Embolization in Suspected Parauterine Choriocarcinoma. Case Rep Obstet Gynecol. 2016;2016:6353471. doi: 10.1155/2016/6353471. Epub 2016 Jun 14. PMID: 27403360; PMCID: PMC4923520.
Copy Download .nbib Format: NLM
Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.

Radiation oncology journal

Byun HK, Yoon HI, Cho J, Kim HJ, Min YH, Lyu CJ, Cheong JW, Kim JS, Kim HS, Kim SJ, Yang AJ, Lee BM, Lee WH, Lee J, Ahn KJ, Suh CO.
PMID: 29037020
Radiat Oncol J. 2017 Sep;35(3):257-267. doi: 10.3857/roj.2017.00290. Epub 2017 Sep 29.

PURPOSE: Pulmonary toxicities, including infectious pneumonia (IP) and idiopathic pneumonia syndrome (IPS), are serious side effects of total body irradiation (TBI) used for myeloablative conditioning. This study aimed to evaluate clinical factors associated with IP and IPS following TBI.MATERIALS...

Cite
Byun HK, Yoon HI, Cho J, et al. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation. Radiat Oncol J. 2017;35(3):257-267doi: 10.3857/roj.2017.00290.
Byun, H. K., Yoon, H. I., Cho, J., Kim, H. J., Min, Y. H., Lyu, C. J., Cheong, J. W., Kim, J. S., Kim, H. S., Kim, S. J., Yang, A. J., Lee, B. M., Lee, W. H., Lee, J., Ahn, K. J., & Suh, C. O. (2017). Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation. Radiation oncology journal, 35(3), 257-267. https://doi.org/10.3857/roj.2017.00290
Byun, Hwa Kyung, et al. "Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation." Radiation oncology journal vol. 35,3 (2017): 257-267. doi: https://doi.org/10.3857/roj.2017.00290
Byun HK, Yoon HI, Cho J, Kim HJ, Min YH, Lyu CJ, Cheong JW, Kim JS, Kim HS, Kim SJ, Yang AJ, Lee BM, Lee WH, Lee J, Ahn KJ, Suh CO. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation. Radiat Oncol J. 2017 Sep;35(3):257-267. doi: 10.3857/roj.2017.00290. Epub 2017 Sep 29. PMID: 29037020; PMCID: PMC5647754.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 4454 entries